Clinical Laboratories

Laboratory investments in remote diagnostic workflows were intended as lasting structural changes rather than temporary adaptations. Clinical laboratories made substantial investments in secure digital infrastructure, governance, and remote diagnostic workflows after regulatory flexibility was introduced. Laboratories that invested in validated and secure remote cytology review now face restrictions that may reduce care quality and accessibility.